Dodge & Cox’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $831M | Buy |
15,108,310
+153,070
| +1% | +$8.41M | 0.47% | 64 |
|
|
2025
Q1 | $1.06B | Buy |
14,955,240
+209,005
| +1% | +$14.8M | 0.6% | 57 |
|
|
2024
Q4 | $969M | Buy |
14,746,235
+847,917
| +6% | +$55.7M | 0.56% | 63 |
|
|
2024
Q3 | $977M | Sell |
13,898,318
-32,175
| -0.2% | -$2.26M | 0.55% | 62 |
|
|
2024
Q2 | $1.15B | Sell |
13,930,493
-62,450
| -0.4% | -$5.14M | 0.69% | 53 |
|
|
2024
Q1 | $1.22B | Sell |
13,992,943
-1,120
| -0% | -$97.8K | 0.71% | 51 |
|
|
2023
Q4 | $1.35B | Sell |
13,994,063
-159,440
| -1% | -$15.4M | 0.86% | 45 |
|
|
2023
Q3 | $1.25B | Sell |
14,153,503
-136,800
| -1% | -$12.1M | 0.84% | 50 |
|
|
2023
Q2 | $1.24B | Sell |
14,290,303
-39,010
| -0.3% | -$3.38M | 0.83% | 46 |
|
|
2023
Q1 | $1.39B | Sell |
14,329,313
-54,350
| -0.4% | -$5.28M | 0.95% | 41 |
|
|
2022
Q4 | $1.49B | Sell |
14,383,663
-390,300
| -3% | -$40.4M | 1.02% | 36 |
|
|
2022
Q3 | $1.25B | Sell |
14,773,963
-233,100
| -2% | -$19.8M | 0.95% | 42 |
|
|
2022
Q2 | $1.24B | Sell |
15,007,063
-27,936
| -0.2% | -$2.32M | 0.86% | 47 |
|
|
2022
Q1 | $1.16B | Buy |
15,034,999
+209,950
| +1% | +$16.2M | 0.7% | 51 |
|
|
2021
Q4 | $1.31B | Buy |
14,825,049
+6,467
| +0% | +$571K | 0.81% | 46 |
|
|
2021
Q3 | $1.15B | Buy |
14,818,582
+716,485
| +5% | +$55.4M | 0.75% | 50 |
|
|
2021
Q2 | $1.18B | Buy |
14,102,097
+2,247,789
| +19% | +$188M | 0.77% | 49 |
|
|
2021
Q1 | $895M | Buy |
11,854,308
+2,057,384
| +21% | +$155M | 0.64% | 52 |
|
|
2020
Q4 | $859M | Buy |
9,796,924
+2,076,701
| +27% | +$182M | 0.68% | 51 |
|
|
2020
Q3 | $587M | Buy |
7,720,223
+4,104,483
| +114% | +$312M | 0.54% | 57 |
|
|
2020
Q2 | $446M | Sell |
3,615,740
-326,768
| -8% | -$40.3M | 0.41% | 63 |
|
|
2020
Q1 | $333M | Sell |
3,942,508
-447,007
| -10% | -$37.8M | 0.36% | 61 |
|
|
2019
Q4 | $371M | Buy |
+4,389,515
| New | +$371M | 0.28% | 72 |
|